| Cat. No. |
产品名 |
作用方式
|
纯度 |
是否罕见病
|
| HY-B0762S1 |
Acetyl-L-carnitine-d3-1 hydrochloride |
Inhibitor |
99.12% |
否 |
| HY-B0892S4 |
Benzyl alcohol-d1 |
|
95.05% |
否 |
| HY-B0151S2 |
Pregnenolone-d4-1 |
|
99.34% |
否 |
| HY-B0228S |
Adenosine-d1 |
|
99.72% |
否 |
| HY-B0511S |
Biotin-d2-1 |
|
99.65% |
否 |
| HY-W013049S4 |
Docosanoic acid-d4-1 |
Inhibitor |
99.26% |
否 |
| HY-13966S |
2-Deoxy-D-glucose-d1 |
|
≥98.0% |
否 |
| HY-153939S |
Idasanutlin-d3-1 |
|
99.57% |
否 |
| HY-B0152S |
Adenine-d1 |
Chemical |
99.90% |
否 |
| HY-B0389S1 |
D-Glucose-d1 |
|
99.86% |
否 |
| HY-78518S1 |
o-Diaminobenzene-d4 |
|
/ |
否 |
| HY-130462S |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 |
|
≥99.0% |
否 |
| HY-B0389S8 |
D-Glucose-d1-4 |
|
≥98.0% |
否 |
| HY-N0229S4 |
L-Alanine-13C,d1 |
|
≥98.0% |
否 |
| HY-W040193S |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d70 |
|
≥99.0% |
否 |
| HY-W050145S |
Levoglucosan-d7 |
|
≥99.0% |
否 |
| HY-100442S1 |
Paquinimod-d5-1 |
Inhibitor |
98.19% |
否 |
| HY-113139S |
1-Methylinosine-d3 |
|
≥99.0% |
否 |
| HY-17376S1 |
Ezetimibe-d4-1 |
|
99.26% |
否 |
| HY-B0402S |
Amantadine-d15 |
|
98.13% |
否 |
| HY-Y1039S1 |
1-Stearoyl-rac-glycerol-d35 |
|
99.04% |
否 |
| HY-113123S1 |
LysoPC(14:0/0:0)-d7 |
|
95.4% |
否 |
| HY-20600S |
Iodomethane-d1 |
|
/ |
否 |
| HY-90006S |
5-Fluorouracil-d1 |
|
99.42% |
否 |
| HY-10162S3 |
Olaparib-d4-1 |
|
98.59% |
否 |
| HY-15025S2 |
Sildenafil-d3-1 |
|
99.47% |
否 |
| HY-76025S |
1,4-Dibromobenzene-d4 |
|
99.90% |
否 |
| HY-B0228S8 |
Adenosine-d1-2 |
|
99.72% |
否 |
| HY-B0234S4 |
Estrone-d2-1 |
Agonist |
≥95.0% |
否 |
| HY-W013504S |
1-Bromo-4-(trifluoromethyl)benzene-d4 |
|
/ |
否 |
| HY-W242724 |
1,4-Dibromo-butane-1,1,2,2,3,3,4,4-d8 |
|
99.91% |
否 |
| HY-W768340 |
Sucrose-13C6-1 |
|
/ |
否 |
| HY-109541S2 |
Colfosceril miristate-d9 |
|
≥99.0% |
否 |
| HY-15780S1 |
Brexpiprazole-d8-1 |
|
96.48% |
否 |
| HY-B0389S7 |
D-Glucose-d1-3 |
|
99.90% |
否 |
| HY-W032013S |
1-Octanol-d17 |
|
99.09% |
否 |
| HY-W131797 |
1-Iodoethane-1,1,2,2,2-d5 |
|
99.58% |
否 |
| HY-B0389S2 |
D-Glucose-d12-1 |
|
99.4% |
否 |
| HY-107343S1 |
Docosahexaenoic acid ethyl ester-d5-1 |
|
/ |
否 |
| HY-109506S3 |
DPPC-d9-1 |
|
≥99.0% |
否 |
| HY-113424AS |
1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9 |
|
≥98.0% |
否 |
| HY-115702S |
1-Palmityl-2-O-acetyl-3-glyceryl phosphorylcholine-d4 |
|
≥99.0% |
否 |
| HY-14648S5 |
Dexamethasone-d3-1 |
|
98.02% |
否 |
| HY-W009719S |
1-Bromo-2,3-dichlorobenzene-d3 |
|
/ |
否 |
| HY-Y0308S |
Phosphate dibasic-d1(sodium) |
|
≥99.0% |
否 |
| HY-Y0921S2 |
(±)-1,2-Propanediol-d6 |
|
≥99.0% |
否 |
| HY-113136S |
1-Methylguanosine-d3 |
|
99.50% |
否 |
| HY-33948S |
1-Amino-2-methylpropan-2-ol-d6 |
|
/ |
否 |
| HY-B0166S8 |
L-Ascorbic acid-13C6-1 |
|
99.15% |
否 |
| HY-W040193S3 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d83 |
|
/ |
否 |
| HY-W040193S4 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d4 |
|
≥99.0% |
否 |
| HY-W097453S2 |
6-(Methylthio)purine-d3-1 |
|
99.56% |
否 |
| HY-W1115209 |
1,3,5-Tribromo-2-iodobenzene-d2 |
|
/ |
否 |
| HY-Y1275S |
N-Methylpyrrolidone-d9 |
|
98% |
否 |
| HY-W050145S2 |
Levoglucosan-13C6 |
|
/ |
否 |
| HY-15029S1 |
(±)-Naproxen-d3-1 |
|
/ |
否 |
| HY-W013376S |
Norcyclizine-d8 |
|
/ |
否 |
| HY-10003S |
Alfacalcidol-d7 |
Activator |
/ |
否 |
| HY-100441S1 |
Treprostinil-13C2,d1 |
Inhibitor |
/ |
否 |
| HY-10284S3 |
Linagliptin-d3-1 |
|
/ |
否 |
| HY-10585S4 |
Valproic acid-d4-1 |
|
/ |
否 |
| HY-10846S1 |
Delamanid-d4-1 |
|
/ |
否 |
| HY-108506S2 |
Licarbazepine-d4-1 |
Inhibitor |
/ |
否 |
| HY-109541S |
Colfosceril miristate-d58 |
|
99.3% |
否 |
| HY-109541S1 |
Colfosceril miristate-d4 |
|
/ |
否 |
| HY-109541S3 |
Colfosceril miristate-d13 |
|
/ |
否 |
| HY-109541S4 |
Colfosceril miristate-d63 |
|
/ |
否 |
| HY-109541S5 |
Colfosceril miristate-d67 |
|
≥99.0% |
否 |
| HY-11018S1 |
Risperidone-d4-1 |
|
/ |
否 |
| HY-112530S |
1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine-d70 |
|
≥99.0% |
否 |
| HY-114041S1 |
Resolvin E1-d4-1 |
|
/ |
否 |
| HY-122272S2 |
Paroxetine-d6-1 |
Inhibitor |
/ |
否 |
| HY-122426S1 |
1-Bromoundecane-d3 |
|
/ |
否 |
| HY-122426S2 |
1-Bromoundecane-d4 |
|
/ |
否 |
| HY-12516S2 |
Desogestrel-13C2,d2-1 |
|
/ |
否 |
| HY-125771S |
1-Stearoyl-sn-glycero-3-phosphocholine-d35 |
|
/ |
否 |
| HY-12650S |
Mirogabalin-13C2,d1 (Mixture of Diastereomers) |
|
/ |
否 |
| HY-12773AS1 |
5-Hydroxy Propafenone-d5-1 hydrochloride |
|
/ |
否 |
| HY-12987S2 |
Pimozide-d4-1 |
Inhibitor |
/ |
否 |
| HY-130462S1 |
1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 |
|
/ |
否 |
| HY-135810S1 |
Cletoquine-d4-1 |
Inhibitor |
/ |
否 |
| HY-13593S1 |
Chlorambucil-d8-1 |
|
/ |
否 |
| HY-13678S1 |
Meropenem-d6-1 |
Inhibitor |
/ |
否 |
| HY-13956A |
(R)-Pioglitazone-d1 |
|
/ |
否 |
| HY-142555S |
Bisphenol A monosulfate-d6 sodium |
|
/ |
否 |
| HY-14281S2 |
Trilostane-d3-1 |
|
/ |
否 |
| HY-14648S1 |
Dexamethasone-d5-1 |
|
/ |
否 |
| HY-146737S |
Tripentadecanoin-d5 |
|
/ |
否 |
| HY-14956S1 |
Nemonoxacin-d3-1 |
Inhibitor |
/ |
否 |
| HY-151997S |
1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 |
|
/ |
否 |
| HY-152070S1 |
Demethylmaprotiline-d2-1 |
|
/ |
否 |
| HY-15592S2 |
Cabotegravir-d3-1 |
Inhibitor |
/ |
否 |
| HY-15917S1 |
DL-dithiothreitol-d10-1 |
Inhibitor |
/ |
否 |
| HY-17430S1 |
Amprenavir-d4-1 |
Inhibitor |
/ |
否 |
| HY-18341S4 |
L-Thyroxine-13C6-1 |
|
/ |
否 |
| HY-19696S2 |
Tauroursodeoxycholate-d4-1 |
Inhibitor |
/ |
否 |
| HY-23188 |
Loratadine-d5-1 |
|
/ |
否 |
| HY-34123S |
N-(2-Bromoethyl)phthalimide-d4 |
|
/ |
否 |
| HY-34444S |
1,1-Dioxothiolan-d8 |
|
/ |
否 |
| HY-41676S |
4-Chlorobenzonitrile-d4 |
|
/ |
否 |
| HY-41681S |
6-Chloro-1-hexanol-d6 |
|
/ |
否 |
| HY-50898S3 |
Lapatinib-d4-1 |
|
/ |
否 |
| HY-66008S1 |
N-Acetyl mesalazine-d3-1 |
|
/ |
否 |
| HY-66011AS3 |
Moxifloxacin-d3-1 hydrochloride |
Inhibitor |
/ |
否 |
| HY-70057S1 |
Safinamide-d4-1 |
Inhibitor |
/ |
否 |
| HY-79779S1 |
1-Bromo-4-(bromomethyl)benzene-d4 |
|
/ |
否 |
| HY-A0042S2 |
Rufinamide-15N,d2-1 |
Inhibitor |
/ |
否 |
| HY-A0052S |
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 |
|
/ |
否 |
| HY-A0095S1 |
Flibanserin-d4-1 |
Modulator |
99.28% |
否 |
| HY-B0111S1 |
Drospirenone-d4-1 |
Agonist |
/ |
否 |
| HY-B0113S1 |
Omeprazole-d3-1 |
|
95.09% |
否 |
| HY-B0114S1 |
Oxcarbazepine-d4-1 |
|
/ |
否 |
| HY-B0158S3 |
Cytidine-d2-1 |
|
/ |
否 |
| HY-B0158S4 |
Cytidine-d1 |
|
/ |
否 |
| HY-B0196S1 |
Venlafaxine-d6-1 |
Inhibitor |
/ |
否 |
| HY-B0228S7 |
Adenosine-d1-1 |
|
/ |
否 |
| HY-B0389S18 |
D-Glucose-13C3-1 |
|
/ |
否 |
| HY-B0389S23 |
D-Glucose-d2-1 |
|
/ |
否 |
| HY-B0389S25 |
D-Glucose-13C,d1 |
|
/ |
否 |
| HY-B0389S3 |
D-Glucose-d1-1 |
|
/ |
否 |
| HY-B0389S4 |
D-Glucose-d1-2 |
|
/ |
否 |
| HY-B0400S7 |
D-Sorbitol-d1-2 |
|
/ |
否 |
| HY-B0400S8 |
D-Sorbitol-d2-1 |
|
/ |
否 |
| HY-B0402S1 |
Amantadine-d6 |
|
98.10% |
否 |
| HY-B0412S4 |
Estriol-d3-1 |
Antagonist |
/ |
否 |
| HY-B0451AS3 |
Dopamine-d2-1 hydrochloride |
|
/ |
否 |
| HY-B0456S1 |
Riboflavin-5-Phosphate-13C4,15N2-1 |
|
/ |
否 |
| HY-B0561S2 |
Spironolactone-d3-1 |
|
/ |
否 |
| HY-B0740S3 |
Cyclobenzaprine-d3-1 hydrochloride |
|
/ |
否 |
| HY-B0763S2 |
Ibudilast-d7-1 |
|
/ |
否 |
| HY-B0896S1 |
Triacetin-d5 |
Inhibitor |
/ |
否 |
| HY-B0896S2 |
Triacetin-d9 |
|
/ |
否 |
| HY-B0901S1 |
Bromperidol-d4-1 |
Inhibitor |
/ |
否 |
| HY-B1411S1 |
i-Inositol-d1 |
|
99.46% |
否 |
| HY-B1659S3 |
Glycerol-d1 |
|
/ |
否 |
| HY-B1716S1 |
L-5-Hydroxytryptophan-d3-1 |
|
/ |
否 |
| HY-D0837S |
Imidazole-d4 |
|
/ |
否 |
| HY-G0016S1 |
N-Acetyl dapsone-d4-1 |
|
/ |
否 |
| HY-N0131S1 |
Stigmasterol-d5-1 |
|
/ |
否 |
| HY-N0210S11 |
D-Galactose-d2-1 |
|
/ |
否 |
| HY-N0210S12 |
D-Galactose-13C,d1 |
|
/ |
否 |
| HY-N0210S5 |
D-Galactose-d1 |
|
/ |
否 |
| HY-N0210S6 |
D-Galactose-d1-1 |
|
/ |
否 |
| HY-N0210S7 |
D-Galactose-d1-2 |
|
/ |
否 |
| HY-N0210S8 |
D-Galactose-d1-3 |
|
/ |
否 |
| HY-N0215S13 |
L-Phenylalanine-d1 |
Antagonist |
/ |
否 |
| HY-N0378S5 |
D-Mannitol-d1 |
|
/ |
否 |
| HY-N0384S4 |
Homovanillic acid-d3-1 |
|
/ |
否 |
| HY-N0537S12 |
Xylose-d1-3 |
|
/ |
否 |
| HY-N0537S13 |
Xylose-d1-4 |
|
/ |
否 |
| HY-N0717S8 |
L-Valine-d1 |
|
/ |
否 |
| HY-N1380S4 |
Guaiacol-d4-1 |
|
/ |
否 |
| HY-N1429S2 |
Taurochenodeoxycholic acid-d4-1 sodium |
Inducer |
/ |
否 |
| HY-N7092S18 |
D-Fructose-d2-1 |
|
/ |
否 |
| HY-P10215 |
Ac-{Cpg}-Thr-Ala-{Ala(CO)}-Asp-{Cpg}-NH2 |
Inhibitor |
/ |
否 |
| HY-RS13999 |
SUB1 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
| HY-W004263S |
1-Eicosanol-d41 |
|
/ |
否 |
| HY-W004292S |
1-Undecanol-d23 |
|
/ |
否 |
| HY-W004292S1 |
1-Undecanol-d4 |
|
/ |
否 |
| HY-W004293S |
1-Tridecanol-d27 |
|
/ |
否 |
| HY-W009981S |
1-Bromo-2,4-difluorobenzene-d3 |
|
/ |
否 |
| HY-W010265S |
Butyrophenone-d5 |
|
/ |
否 |
| HY-W011883S |
1,3-Dibromo-5-fluorobenzene-d3 |
|
/ |
否 |
| HY-W012856S |
1-Ethyl-3-methylbenzene-d5 |
|
/ |
否 |
| HY-W013053S |
Dibenz[a,h]anthracene-d14 |
|
/ |
否 |
| HY-W013948S |
1-(2,4-Dinitrophenyl)-2-propylidenehydrazine-d3 |
|
/ |
否 |
| HY-W014286S |
1,3-Diphenylurea-d10 |
|
/ |
否 |
| HY-W014431S |
1-Bromo-3-chloro-5-fluorobenzene-d3 |
|
/ |
否 |
| HY-W014559S3 |
1-Bromononane-d4-1 |
|
/ |
否 |
| HY-W015784S |
1,4-Benzenedimethanol-d4 |
|
/ |
否 |
| HY-W015824S3 |
DL-Aspartic acid-13C1 |
|
/ |
否 |
| HY-W015849S |
1-Fluoro-4-methoxybenzene-d4 |
|
/ |
否 |
| HY-W016577S3 |
1-Bromoheptane-d7 |
|
/ |
否 |
| HY-W016577S4 |
1-Bromoheptane-d1 |
|
/ |
否 |
| HY-W016931S |
1-Bromo-4-chlorobutane-d8 |
|
/ |
否 |
| HY-W017142S |
1-(Benzyloxy)propan-2-ol-d6 |
|
/ |
否 |
| HY-W017522S5 |
Adipic acid-d4-1 |
Inhibitor |
/ |
否 |
| HY-W017554S |
1-Chloro-2-methoxybenzene-d3 |
|
/ |
否 |
| HY-W032013S1 |
1-Octanol-d2 |
|
/ |
否 |
| HY-W032015S3 |
1-Bromooctane-d4 |
|
/ |
否 |
| HY-W040193S1 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d74 |
|
/ |
否 |
| HY-W040193S2 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d79 |
|
99.3% |
否 |
| HY-W040193S5 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d9 |
|
≥99.0% |
否 |
| HY-W040193S6 |
1,2-Distearoyl-sn-glycero-3-phosphorylcholine-d13 |
|
≥99.0% |
否 |
| HY-W048482S |
rU Phosphoramidite-13C2,d1 |
|
/ |
否 |
| HY-W052227S |
Fmoc-DL-Ala-OH-d1 |
|
/ |
否 |
| HY-W087024S |
1-Phenylpentane-d5 |
|
/ |
否 |
| HY-W094751S |
1-Pyrenamin-d9 |
|
/ |
否 |
| HY-W099504S1 |
1-Heptanol-d7 |
|
/ |
否 |
| HY-W099504S2 |
1-Heptanol-d1 |
|
/ |
否 |
| HY-W099521S |
1-Chlorooctane-d17 |
|
/ |
否 |
| HY-W101642S |
1,3-Diisopropylbenzene-d18 |
|
/ |
否 |
| HY-W101971S |
1-(4-Chlorophenyl)-2-methylpropan-2-ol-d6 |
|
/ |
否 |
| HY-W105111S |
1-Bromo-2,3,5-trichlorobenzene-d2 |
|
/ |
否 |
| HY-W130478S |
1-Phenylhexane-d5 |
|
/ |
否 |
| HY-W142175S |
1-Butynylbenzene-d5 |
|
/ |
否 |
| HY-W654010 |
Lurasidone-d8-1 hydrochloride |
|
/ |
否 |
| HY-W654074 |
1,2-Dilauroyl-3-chloropropanediol-d5 |
|
/ |
否 |
| HY-W699983 |
Imidazole-15N2 |
Inhibitor |
/ |
否 |
| HY-W709612 |
Regorafenib N-oxide and N-desmethyl (M5)-d3-1 |
|
/ |
否 |
| HY-W711089 |
Bifenox-d3-1 |
|
/ |
否 |
| HY-W711733 |
1-Bromopropane-d7 |
|
/ |
否 |
| HY-W716213 |
1-(2,4-Dimethoxyphenyl)ethanone-d6 |
|
/ |
否 |
| HY-W719338 |
Pentane-1,2-diol-d7 |
|
/ |
否 |
| HY-W720915 |
N-Dodecylbenzene-d5 |
|
/ |
否 |
| HY-W740373 |
1-Methylpiperidin-4-ol-d4 |
|
/ |
否 |
| HY-W749377 |
1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 |
|
/ |
否 |
| HY-W751665 |
1-(Adamantan-1-yl)ethan-1-one-d3 |
|
/ |
否 |
| HY-W752616 |
1-Aminopropan-2-ol-d6 |
|
/ |
否 |
| HY-W754348 |
1-(2,6-Dimethylphenoxy)propan-2-one-d5 |
|
/ |
否 |
| HY-W766078 |
1-beta-D-Arabinofuranosyluracil-13C,15N2 |
|
/ |
否 |
| HY-W767978 |
1-(4,4-Dimethylthiochroman-6-yl)ethanone-d8 |
|
/ |
否 |
| HY-W768181 |
1,5-Anhydrosorbitol-13C6 |
|
/ |
否 |
| HY-W770203 |
1-Oleoyl-2-linoleoyl-rac-glycerol-d5 |
|
/ |
否 |
| HY-W777094 |
1-Acetyl-4-(4-hydroxyphenyl)piperazine-d8 |
|
/ |
否 |
| HY-W777620 |
1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C,d3 |
|
/ |
否 |
| HY-W777706 |
1-(3,4-Dimethylphenyl)ethan-1-ol-13C,d3 |
|
/ |
否 |
| HY-W778692 |
1-Linoleoyl Glycerol-d5 |
|
/ |
否 |
| HY-W778954 |
2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3 |
|
/ |
否 |
| HY-Y0001S1 |
Cyclopropylcarboxylic acid-d1 |
|
/ |
否 |
| HY-Y0093S |
NSC 5416-d14 |
|
/ |
否 |
| HY-Y0219S |
1,2,4-Triazole-13C2,15N3 |
|
/ |
否 |
| HY-Y0219S1 |
1,2,4-Triazole-d3 |
|
/ |
否 |
| HY-Y0531S |
1-Adamantanol-d15 |
|
/ |
否 |
| HY-Y0727S |
1,5-Dibromopentane-d4 |
|
/ |
否 |
| HY-Y0727S1 |
1,5-Dibromopentane-d10 |
|
/ |
否 |
| HY-Y0860S |
1,6-Dibromo-n-hexane-d12 |
|
/ |
否 |
| HY-Y0921S |
(±)-1,2-Propanediol-d8 |
|
99.55% |
否 |
| HY-Y0921S1 |
(±)-1,2-Propanediol-d2 |
|
/ |
否 |
| HY-Y0921S3 |
(±)-1,2-Propanediol-13C3 |
|
/ |
否 |
| HY-Y1004S3 |
1-Decanol-d5 |
|
/ |
否 |
| HY-Y1004S4 |
1-Decanol-d4 |
|
/ |
否 |
| HY-Y1039S |
1-Stearoyl-rac-glycerol-d40 |
|
/ |
否 |
| HY-Y1044S |
1,5-Dihydroxypentane-d10 |
|
/ |
否 |
| HY-Y1139S |
Pimelic acid-d4 |
|
/ |
否 |
| HY-Y1217S |
1-Cyclohexanol-d12 |
|
/ |
否 |
| HY-Y1217S1 |
1-Cyclohexanol-d11 |
|
/ |
否 |
| HY-Y1309S |
1-Naphthol-d8 |
|
/ |
否 |
| HY-Y1641S |
1,2-Ethanedithiol-d4 |
|
/ |
否 |
| HY-Y1772S |
1-Iodo-4-methylbenzene-d7 |
|
/ |
否 |
| HY-109037S2 |
Mavacamten-d1 |
Modulator |
/ |
否 |
| HY-113482S |
1β-Hydroxydeoxycholic acid-d5 |
|
/ |
否 |
| HY-114553S |
1-(5-Fluoropentyl)-1H-indole-3-carboxylic acid-d5 |
|
/ |
否 |
| HY-124891S |
1-Phenylpyrrole-d9 |
|
/ |
否 |
| HY-128429S |
trans-2-Hexenal-d2-1 |
Inhibitor |
/ |
否 |
| HY-128792S |
1,3-Dipalmitin-d6 |
|
≥98.0% |
否 |
| HY-131325S |
Simeton-d3 |
|
/ |
否 |
| HY-13331S2 |
Clascoterone-d5-1 |
Antagonist |
/ |
否 |
| HY-13631ES2 |
Deruxtecan-d4-1 |
|
/ |
否 |
| HY-141636S |
1-PalMitoyl-2-arachidoyllecithin-d9-1 |
|
/ |
否 |
| HY-145473S |
1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PE-d11 |
|
/ |
否 |
| HY-14649S6 |
Retinoic acid-d3-1 |
Agonist |
/ |
否 |
| HY-146829S |
1-Pentadecanoyl-2-oleoyl-sn-glycero-3-phosphate-d7 sodium |
|
/ |
否 |
| HY-16504S |
Treprostinil-13C2-d1 Sodium |
Agonist |
/ |
否 |
| HY-17043S2 |
Loratadine-d4-1 |
|
/ |
否 |
| HY-17386S2 |
Rosiglitazone-d4-1 |
|
/ |
否 |
| HY-19822S1 |
Elacestrant-d4-1 |
Inhibitor |
/ |
否 |
| HY-34487S3 |
1,3-Dimethoxybenzene-d3 |
|
/ |
否 |
| HY-41700S2 |
D-Alanine-d1 |
|
/ |
否 |
| HY-59354S1 |
1,2-Dihydropyridazine-3,6-dione-3,4,5,6-13C4 |
Inhibitor |
/ |
否 |
| HY-78004S1 |
1,2-Diphenylethane-d4 |
|
/ |
否 |
| HY-79779S |
1-Bromo-4-(bromomethyl)benzene-d6 |
|
99.56% |
否 |
| HY-B0122SS1 |
Topiramate-13C6-1 |
|
/ |
否 |
| HY-B0141S6 |
Estradiol-d2-1 |
Agonist |
/ |
否 |
| HY-B0197S |
Naratriptan-d3 |
Agonist |
/ |
否 |
| HY-B0258S1 |
Gemfibrozil-d6-1 |
|
/ |
否 |
| HY-B0479S1 |
Thiamphenicol-d3-1 |
|
≥99.0% |
否 |
| HY-B0492S |
rel-Paroxetine-d4-1 hydrochloride |
|
/ |
否 |
| HY-B0801S4 |
Fexofenadine-d3-1 |
Antagonist |
/ |
否 |
| HY-B1565S |
UV Absorber 326-d3 |
|
/ |
否 |
| HY-B1812S4 |
Veratrole-d2-1 |
Substrate |
/ |
否 |
| HY-N2037AS1 |
Higenamine-d4-1 hydrochloride |
|
/ |
否 |
| HY-N7092S23 |
D-Fructose-13C3-1 |
|
/ |
否 |
| HY-N9933S |
Tauro-β-muricholic acid-d4-1 sodium |
|
/ |
否 |
| HY-RS18793 |
Sub1 Mouse Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
| HY-RS25282 |
Sub1 Rat Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
| HY-W004051S |
1-Bromo-2-chlorobenzene-d4 |
|
≥98.0% |
否 |
| HY-W009293S |
1-(Bis(4-fluorophenyl)methyl)piperazine-d4 |
|
/ |
否 |
| HY-W011885S |
1-Dodecylpyrrolidin-2-one-d6 |
|
/ |
否 |
| HY-W012477S |
1-Hydroxycyclohexyl phenyl ketone-d5 |
|
/ |
否 |
| HY-W012652S |
1,2,3,4-Tetrahydroquinoxaline-d4 |
|
/ |
否 |
| HY-W012934S |
1-Ethylpyrrolidin-2-one-d5 |
|
/ |
否 |
| HY-W016152S |
1-Bromo-3-methoxybenzene-d3 |
|
/ |
否 |
| HY-W032013S2 |
1-Octanol-d2-1 |
Inhibitor |
/ |
否 |
| HY-W032013S3 |
1-Octanol-d5 |
Inhibitor |
/ |
否 |
| HY-W110726S |
1-Octen-3-one-d5 |
|
/ |
否 |
| HY-W110726S1 |
1-Octen-3-one-d3 |
|
/ |
否 |
| HY-W192474S |
1-(Furan-2-yl)ethane-1-thiol-d3 |
|
/ |
否 |
| HY-W245524S |
1,4-Phenylenediamine-15N2 |
|
≥99.0% |
否 |
| HY-W245524S1 |
1,4-Phenylenediamine-d8 |
|
/ |
否 |
| HY-W285163S |
1-Cyclopropyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-d8 |
|
/ |
否 |
| HY-W342440S |
1,1-Diethoxynonane-d10 |
|
/ |
否 |
| HY-W392083S |
(1,3E,5E)-Undeca-1,3,5-triene-d5 |
|
/ |
否 |
| HY-W392083S1 |
(1,3E,5Z)-Undeca-1,3,5-triene-d5 |
|
/ |
否 |
| HY-W572873S |
Ethynylbenzene-d1 |
|
/ |
否 |
| HY-W654320 |
Piperin-d10 |
|
/ |
否 |
| HY-W654353 |
Tauro-α-muricholic acid-d4-1 sodium |
Antagonist |
/ |
否 |
| HY-W654409 |
1,1,1,3,3,3-Hexafluoropropan-2-ol-d2 |
|
/ |
否 |
| HY-W662572S |
Pyroxsulam-d6 |
|
/ |
否 |
| HY-W743123 |
1,3-Dipalmitin-d5 |
|
/ |
否 |
| HY-W756596 |
1,2-Dioctanoyl-3-chloropropanediol-d5 |
|
/ |
否 |
| HY-W762019S |
1,2,3,4,7,8-Hexachloro dibenzo-p-dioxin-13C12 |
|
/ |
否 |
| HY-W777599 |
(±)-Naproxen-13C,d3-1 |
|
/ |
否 |
| HY-W777649 |
Oxypurinol-13C,15N2-1 |
Inhibitor |
/ |
否 |
| HY-Y0045S |
2-Acetylthiazole-13C2 |
|
/ |
否 |
| HY-Y0058S1 |
o-Xylene-d6 |
|
/ |
否 |
| HY-Y0566S |
1,4-Diazabicyclo[2.2.2]octane-d12 |
|
99.60% |
否 |
| HY-Y0659S |
1,2,3,4-Hydroquinoline-d2 |
|
/ |
否 |
| HY-Y0678S |
1,3,5-Trimethoxybenzene-d3 |
|
/ |
否 |
| HY-Y0743S |
1-(Pyridin-2-yl)ethan-1-one-d6 |
|
/ |
否 |
| HY-Y1309S1 |
1-Naphthol-d7 |
|
/ |
否 |
| HY-Y1805S |
1,2,3,4-Tetrahydronaphthalene-d4 |
|
/ |
否 |
